$ESTA News
Last published 1w ago
- 1w agoESTAEstablishment Labs Third Quarter 2026 Financial Results - ESTABLISHMENT LABS HOLDINGS INCEarnings Call TranscriptsGood morning. Welcome to the Establishment Lab's third quarter 2026 earnings call. At this time, all participants are in a listen-only mode. At the end of this call, we will open the line for a question-and-answer sessio
- 1w agoESTAESTABLISHMENT LABS HOLDINGS INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoESTAEstablishment Labs® Reports Third Quarter 2026 Financial ResultsBusiness WireRevenue Increases 33.9% to $72.0 Million, Driven by 119% U.S. Growth Achieves First Quarter of Positive Operating and Free Cash Flow and Raises Full-Year Revenue Guidance Establishment Labs Holdings Inc.
- 3w agoESTAEstablishment Labs® to Announce Third Quarter 2026 Financial Results on October 29Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 1mo agoESTAEstablishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food
- 1mo agoESTAEstablishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic ImplantsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of
- 2mo agoCNXUESTAEOLSINMD+1A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to CapturePR NewswireEquity Insider News Commentary - The global medical aesthetics market has quietly become one of the most durable growth stories in healthcare....
- 3mo agoCNXUESTALLYABBV+1The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built ForGlobeNewswireRENO, Nev., Aug. 12, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary - The weight-loss drug boom has been one of the defining healthcare stories of the decade, and its success has created a second-order
- 3mo agoESTAEstablishment Labs® Reports Second Quarter 2026 Financial ResultsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 3mo agoESTAEstablishment Labs® to Announce Second Quarter 2026 Financial Results on August 6Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 4mo agoESTAEstablishment Labs® Appoints Taylor Harris to Board of DirectorsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today the
- 4mo agoCNXUGALDYINMDESTA+1The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for ItGlobeNewswireIssued on behalf of Conexeu Sciences Inc. With Galderma now presenting clinical data on treating medication-driven facial volume loss, the GLP-1 aesthetics category has gone mainstream — and Conexeu Sciences Inc.
- 4mo agoESTAEstablishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® IndexBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of
- 4mo agoCNXUSNNABBVESTA+1Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma FirepowerPR NewswireAmerican News Group News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then ...
- 5mo agoCNXUESTAINMDPCRX+1After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast InsteadGlobeNewswireConexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue
- 5mo agoAXGNCNXUDDDESTA+1The Newest Name on Nasdaq Wants to Help the Body Rebuild ItselfGlobeNewswireIssued on behalf of Conexeu Sciences Inc.A biotech debut out of Reno is betting that the next wave of medicine won't replace tissue — it'll grow it back.NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News
- 5mo agoESTARoute 92 Medical Announces Appointment of Raj Denhoy as Chief Financial OfficerGlobeNewswireWEST JORDAN, Utah, May 18, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today
- 6mo agoESTAEstablishment Labs Reports First Quarter 2026 Financial ResultsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 6mo agoESTAEstablishment Labs® Refinances Credit FacilityBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered
- 6mo agoESTAEstablishment Labs® to Announce First Quarter 2026 Financial Results on May 6Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 7mo agoESTAEstablishment Labs® Surpasses More Than Five Million Motiva® Devices in MarketBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has
- 8mo agoESTAEstablishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 GuidanceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 8mo agoESTAGCOEstablishment Labs Announces Leadership Transition to Support Next Phase of GrowthBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic
- 8mo agoESTAEstablishment Labs to Present at TD Cowen's 46th Annual Health Care ConferenceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
- 9mo agoESTAEstablishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 10mo agoESTAEstablishment Labs to Present at 44th Annual J.P. Morgan Healthcare ConferenceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter
- 10mo agoESTAEstablishment Labs Submits to FDA for Approval of Motiva Implants in Breast ReconstructionBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has
- 1y agoESTAEstablishment Labs to Present at Jefferies London Healthcare ConferenceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
- 1y agoESTAEstablishment Labs Reports Third Quarter 2025 Financial ResultsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 1y agoESTAEstablishment Labs to Announce Third Quarter 2025 Financial Results on November 5Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 1y agoESTAEstablishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance ReportBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced publication of its
- 1y agoESTAArkose Labs Holdings, Inc. vs DataDome S.A. et al. - AIA Trial, Institution DeniedUS Patent Trial and Appeal Board
- 1y agoESTAArkose Labs Holdings, Inc. vs DataDome S.A. et al. - AIA Trial, Institution DeniedUS Patent Trial and Appeal Board
- 1y agoESTAEstablishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoESTAEstablishment Labs Reports Second Quarter 2025 Financial ResultsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 1y agoESTAEstablishment Labs to Announce Second Quarter 2025 Financial Results on August 7Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 1y agoESTAEstablishment Labs Hosting Investor Day on June 12Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously
- 1y agoESTAEstablishment Labs to Present at Jefferies Global Healthcare ConferenceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
- 1y agoESTAEstablishment Labs Reports First Quarter 2025 Financial ResultsBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 1y agoESTAEstablishment Labs Appoints Peter Caldini as Chief Executive OfficerBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today the
- 1y agoESTAEstablishment Labs to Announce First Quarter 2025 Financial Results on May 7Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 1y agoESTAEstablishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, provided preliminary first
- 1y agoESTAEstablishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today
- 1y agoESTAEstablishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®PR NewswireEstablishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally ...
- 1y agoESTAEstablishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 GuidanceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial
- 1y agoESTAEstablishment Labs to Present at TD Cowen's 45th Annual Health Care ConferenceBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
- 1y agoESTAEstablishment Labs to Present at Citi's 2025 Unplugged Medtech and Life Sciences Access DayBusiness WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its
- 1y agoESTAEstablishment Labs Launches Preservé™Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness in breast aesthetics and reconstruction, announced it has launched Preservé™
- 1y agoESTAEstablishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26Business WireEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its
- 1y agoESTAEstablishment Labs Announces CEO TransitionBusiness WirePeter Caldini to become Interim CEO effective March 1, 2025 Establishment Labs also announces preliminary unaudited fourth quarter revenue in line with recent guidance Establishment Labs Holdings Inc.